Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.


Race to reach trapped survivors offers hope in Colombia quake zone
France's top court blocks social media ban for under-15s
Japan's record rains strand thousands at Narita airport; kill eight
Wildfires in Britain hit record levels after homes burn in intense heat
